Literature DB >> 22454894

The assessment of β-adrenoceptor blocking drugs in hyperthyroidism.

S G Carruthers1, A Ghosal, D G McDevitt, J K Nelson, R G Shanks.   

Abstract

1 Intravenous propranolol and practolol both reduced resting supine heart rate in patients with hyperthyroidism. Propranolol produced a significantly greater reduction than practolol, which did not have a dose-dependent effect. 2 The effect of these drugs on resting heart rate was much less than their effect on the tachycardias produced both by severe exercise and by standing upright in hyperthyroid patients. Propranolol again produced a significantly greater reduction than practolol in each situation, but practolol did have a dose dependent effect on exercise heart rate. 3 The percentage reduction of standing tachycardia produced by the two drugs appeared to parallel closely the reduction in exercise tachycardia. 4 It is concluded that a simple and convenient way of assessing the activity of β-adrenoceptor blocking drugs in hyperthyroid patients would be to measure their effect on the tachycardia induced by standing. Their effect on resting heart rate should not be used. 5 Practolol may be useful in the management of hyperthyroidism in patients in whom propranolol and similar non-selective β-adrenoceptor blocking drugs are contraindicated.

Entities:  

Year:  1974        PMID: 22454894      PMCID: PMC1402445          DOI: 10.1111/j.1365-2125.1974.tb00216.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

1.  A new test of the degree of adrenergic beta receptor blockade.

Authors:  J D Fitzgerald
Journal:  Int Z Klin Pharmakol Ther Toxikol       Date:  1970-12

Review 2.  Clinical pharmacology of beta-receptor-blocking drugs.

Authors:  C T Dollery; J W Paterson; M E Conolly
Journal:  Clin Pharmacol Ther       Date:  1969 Nov-Dec       Impact factor: 6.875

3.  Practolol in hyperthyroid cardiac failure.

Authors:  S Epstein; B Pimstone
Journal:  S Afr Med J       Date:  1971-07-24

4.  Alprenolol and propranolol in hyperthyroid tachycardia.

Authors:  P Turner
Journal:  Br J Pharmacol       Date:  1970-09       Impact factor: 8.739

5.  Selective blockade of adrenoceptive beta receptors in the heart.

Authors:  D Dunlop; R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1968-01

6.  Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exercise.

Authors:  I Brick; K J Hutchison; D G McDevitt; I C Roddie; R G Shanks
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

7.  A comparison of three beta-adrenergic receptor-blocking drugs in thyrotoxic tachycardia.

Authors:  P Turner; R C Hill
Journal:  J Clin Pharmacol J New Drugs       Date:  1968 Jul-Aug

8.  Duration of action of beta-blocking drugs.

Authors:  S G Carruthers; J G Kelly; D G McDevitt; R G Shanks; M J Walsh
Journal:  Br Med J       Date:  1973-04-21

9.  Comparison of propranolol and Ro 3-3528 in hyperthyroid tachycardia and dysrhythmias.

Authors:  E M Phillips; P Turner; J Houghton; D G Ferriman
Journal:  Postgrad Med J       Date:  1973-01       Impact factor: 2.401

10.  Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in man.

Authors:  J M Kofi Ekue; D C Lowe; R G Shanks
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739

View more
  6 in total

1.  The clinical importance of the sympathetic nervous system in Graves' disease.

Authors:  D G McDevitt
Journal:  Ir J Med Sci       Date:  1977-11       Impact factor: 1.568

Review 2.  Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.

Authors:  J Feely
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

Review 3.  Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

Authors:  J Feely; N Peden
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

4.  Cardioselectivity of atenolol in asthmatic patients.

Authors:  M E Ellis; J N Sahay; S S Chatterjee; J M Cruickshank; S H Ellis
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

Review 5.  The clinical pharmacology of beta adrenergic blocking drugs.

Authors:  D G McDevitt; R G Shanks; B N Prichard
Journal:  J R Coll Physicians Lond       Date:  1976-10

Review 6.  Uses of beta-adrenoceptor blocking drugs.

Authors:  B N Prichard; D G McDevitt; R G Shanks
Journal:  J R Coll Physicians Lond       Date:  1976-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.